Please login to the form below

Not currently logged in
Email:
Password:

MM-398

This page shows the latest MM-398 news and features for those working in and with pharma, biotech and healthcare.

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack file pancreatic cancer drug in EU

Baxter and Merrimack Pharma have filed for approval of their pancreatic cancer therapy MM-398 in the EU, a few days after the FDA started a priority review of the drug. ... Analysts have suggested MM-398 could become a $500m-a-year product at peak.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics